Molecular Imaging with FLT: a Case of Cassandra's Curse?

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2021 Jun 3

PMID 34081154

Authors

Rodney J Hicks

Affiliations

Soon will be listed here.

References

Herrmann K, Ott K, Buck A, Lordick F, Wilhelm D, Souvatzoglou M . Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis. J Nucl Med. 2007; 48(12):1945-50. DOI: 10.2967/jnumed.107.044867. View

Troost E, Vogel W, Merkx M, Slootweg P, Marres H, Peeters W . 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients. J Nucl Med. 2007; 48(5):726-35. DOI: 10.2967/jnumed.106.037473. View

Galldiks N, Lohmann P, Albert N, Tonn J, Langen K . Current status of PET imaging in neuro-oncology. Neurooncol Adv. 2020; 1(1):vdz010. PMC: 7324052. DOI: 10.1093/noajnl/vdz010. View

Nowosielski M, DiFranco M, Putzer D, Seiz M, Recheis W, Jacobs A . An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas. PLoS One. 2014; 9(4):e95830. PMC: 3997484. DOI: 10.1371/journal.pone.0095830. View

Backes H, Ullrich R, Neumaier B, Kracht L, Wienhard K, Jacobs A . Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma. Eur J Nucl Med Mol Imaging. 2009; 36(12):1960-7. PMC: 2779371. DOI: 10.1007/s00259-009-1244-4. View

Yamamoto Y, Ono Y, Aga F, Kawai N, Kudomi N, Nishiyama Y . Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas. J Nucl Med. 2012; 53(12):1911-5. DOI: 10.2967/jnumed.112.104729. View

Hicks R . Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy. Cancer Imaging. 2010; 10 Spec no A:S83-91. PMC: 2967140. DOI: 10.1102/1470-7330.2010.9007. View

Blanchet E, Taieb D, Millo C, Martucci V, Chen C, Merino M . 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study. J Nucl Med. 2015; 56(12):1849-54. PMC: 4668210. DOI: 10.2967/jnumed.115.159061. View

Herrmann K, Buck A, Schuster T, Junger A, Wieder H, Graf N . Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment. J Nucl Med. 2011; 52(5):690-6. DOI: 10.2967/jnumed.110.084566. View

10.

Meagher D, Tasker J . Effects of excitement and tranquilization on the equine hemogram. Mod Vet Pract. 1972; 53(3):41-3. View

11.

Wang R, Zhu H, Chen Y, Li C, Li F, Shen Z . Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT. Hematol Oncol. 2013; 32(3):126-32. DOI: 10.1002/hon.2093. View

12.

Kasper B, Egerer G, Gronkowski M, Haufe S, Lehnert T, Eisenhut M . Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET. Leuk Lymphoma. 2007; 48(4):746-53. DOI: 10.1080/10428190601113568. View

13.

Lee H, Kim S, Kim Y, Kim T, Kang S, Park W . Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma. J Nucl Med. 2013; 55(2):216-22. DOI: 10.2967/jnumed.113.124172. View

14.

Schoder H, Zelenetz A, Hamlin P, Gavane S, Horwitz S, Matasar M . Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma. J Nucl Med. 2016; 57(5):728-34. PMC: 4854760. DOI: 10.2967/jnumed.115.166769. View

15.

Kaida H, Kitajima K, Nakajo M, Ishibashi M, Matsunaga T, Minamimoto R . Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan. Eur J Nucl Med Mol Imaging. 2021; 48(11):3666-3682. DOI: 10.1007/s00259-021-05365-5. View

16.

Beauregard J, Giraudet A, Aide N, Hofman M, Blum R, Drummond E . Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions. Nucl Med Commun. 2013; 34(6):521-6. DOI: 10.1097/MNM.0b013e3283606669. View